Shareholders have faith in loss-making Protagonist Therapeutics (NASDAQ:PTGX) as stock climbs 3.7% in past week, taking five-year gain to 135%
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shareholders might be concerned after seeing the share price drop 10% in the last month. But in stark contrast, the returns over the last half decade have ...